Forecasting Stories
Estimating Alpine Immune (USA Stocks:ALPN) price for May 2024.
 | 2 days ago at Macroaxis By Rifka Kats |
Alpine Immune Sciences has a beta of -0.3738, indicating a potential to outperform the market during uptrends. Conversely, the company may underperform in downturns. Beta is a measure of a stock's volatility in relation to the market, and in this case, suggests that Alpine Immune doesn't move in sync with the broader market. Therefore, while it doesn't significantly increase the risk of a portfolio, it also doesn't contribute much to expected returns.
Key Takeaways
Given Alpine Immune Sciences' (Ticker: ALPN) potential upside of 15.55% and a positive Jensen Alpha of 2.02, there is a promising forecast for substantial growth by May 2024. However, investors should also consider the company's high downside variance of 10.7 and the significant number of shares short the prior month at 5.6M, indicating potential market volatility and investor skepticism. Continue Reading...- ALPN Alpine Immune Sciences
- Latest US STOCKS-SP, Nasdaq rise as fresh inflation data allays rate fears
- ALPN 64.42 0.05
- Low 64.37
- High 64.5
- Volume 3.6 M
- Alpha 1.92
- Beta 1.36
- Return On Equity -0.13
- Return On Asset -0.083
- Profit Margin (0.55) %
- Operating Margin 0.05 %
- Current Valuation 3.9 B
- Shares Outstanding 65.56 M
- Shares Owned By Insiders 4.64 %
- Shares Owned By Institutions 91.41 %
- Number Of Shares Shorted 5.28 M
- Price To Earning (32.69) X
- Price To Book 12.87 X
- Price To Sales 71.68 X
- Revenue 58.88 M
- Gross Profit (40.18 M)
- EBITDA (43.67 M)
- Net Income (32.18 M)
- Cash And Equivalents 167.86 M
- Cash Per Share 5.52 X
- Total Debt 9.91 M
- Debt To Equity 0.17 %
- Current Ratio 2.75 X
- Book Value Per Share 5.43 X
- Cash Flow From Operations (79.01 M)
- Short Ratio 4.15 X
- Earnings Per Share (0.64) X
- Target Price 62.38
- Number Of Employees 142
- Beta 1.17
- Market Capitalization 4.22 B
- Total Asset 381.81 M
- Retained Earnings (256.14 M)
- Working Capital 288.05 M
- Current Asset 25.53 M
- Current Liabilities 3.39 M
- Net Asset 381.81 M
- Accumulation Distribution 7155.28
- Daily Balance Of Power 0.3846
- Rate Of Daily Change 1.0
- Day Median Price 64.44
- Day Typical Price 64.43
- Price Action Indicator 0.01
- Period Momentum Indicator 0.05
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Vlad Skutelnik
Medtronic PLC has a beta of 0.8494, indicating that its returns are likely to increase less than the market during bullish periods. Conversely, in a bear market, the potential loss from holding Medtronic PLC is expected to be less severe. The beta value helps investors gauge if Medtronic PLC's movements align with the broader market and assess its volatility or risk relative to a selected benchmark.
| over a week ago at Macroaxis By Vlad Skutelnik |  |
The article explains how the increasing adoption of cryptocurrency is positively influencing the global economy. It covers aspects such as transparent transactions, widespread financial inclusion, increased investment opportunities, decentralized operations, the introduction of blockchain technology, and improved global trade.
| over three weeks ago at Macroaxis By Nico Santiago |  |
In the world of investing, the sky is indeed the limit. Mesa Air Group (NASDAQ:MESA), a key player in the domestic passenger airlines industry, has recently seen its stock price gain over 1%. With a 52-week high of $3.16 and a current 50-day moving average of $0.94, the question on every investor's mind is whether there's further upside on the horizon.
| over a month ago at Macroaxis By Raphi Shpitalnik |  |
They say timing is everything in the stock market, and for shareholders of Atara Biotherapeutics, a biotechnology firm in the healthcare sector, this adage rings particularly true. With a 52-week high of $4.68, the stock is currently trading at a mere $0.83, a significant drop that may be causing investors to question their holdings. The company's estimated earnings per share (EPS) for the next year is projected to be a loss of $1.48, and with a short ratio of 1.9, it's clear that some investors are betting on the stock's further decline.
| over two months ago at Macroaxis By Rifka Kats | |
The company, American National Bankshares, has a beta of 2.1206. This indicates that the returns of American National are highly sensitive to market fluctuations. As the market experiences ups and downs, American National's performance is expected to mirror these movements.
| over two months ago at Macroaxis By Gabriel Shpitalnik |  |
In the dynamic world of finance, every cloud has a silver lining. Fifth Third Bancorp (FITB), a key player in the financial services sector, has recently experienced a 1% dip in its stock price, defying the broader market trend. This has led some investors to wonder if this could be a potential buying opportunity.
| over two months ago at Macroaxis By Raphi Shpitalnik | |
As the saying goes, "The stock market is a device for transferring money from the impatient to the patient." This seems to be the case with Nicolet Bankshares (USA Stocks: NIC), a regional bank whose impressive price surge has left many investors scratching their heads. With a 52-week high of $84.94 and a current market valuation of $77.45, the bank's performance has been nothing short of remarkable. The estimated EPS for the next year stands at $6.51, a figure that suggests strong future performance.
| over three months ago at Macroaxis By Aina Ster |  |
Unity Bancorp (UNTY) appears to be a potential buying opportunity amid the current market adjustment. The company's Sortino Ratio, a measure used to gauge risk-adjusted return, stands at a respectable 0.07, indicating that the stock has a decent potential for profit when considering its downside risk. Moreover, the firm's Market Risk Adjusted Performance is at 0.23, suggesting that the stock has been performing well in comparison to the inherent risk.
| over three months ago at Macroaxis By Raphi Shpitalnik | |
Volatility is the friend of the long-term investor. Arrowmark Financial Corp's (NASDAQ:BANX) recent price volatility presents a unique opportunity for discerning investors. With a 52-week high of $17.99 and a low of $12.85, the company's stock has demonstrated a noteworthy range, underpinned by a beta of 0.501, indicating lower volatility relative to the broader market.
| over three months ago at Macroaxis By Ellen Johnson |  |